ATE379990T1 - Verfahren zur darstellung von abgestorbenen zellen in-vivo - Google Patents

Verfahren zur darstellung von abgestorbenen zellen in-vivo

Info

Publication number
ATE379990T1
ATE379990T1 AT98920065T AT98920065T ATE379990T1 AT E379990 T1 ATE379990 T1 AT E379990T1 AT 98920065 T AT98920065 T AT 98920065T AT 98920065 T AT98920065 T AT 98920065T AT E379990 T1 ATE379990 T1 AT E379990T1
Authority
AT
Austria
Prior art keywords
vivo
dead cells
displaying
displaying dead
cells
Prior art date
Application number
AT98920065T
Other languages
English (en)
Inventor
Francis Blankenberg
H Strauss
Jonathan Tait
Peter Katsikis
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Application granted granted Critical
Publication of ATE379990T1 publication Critical patent/ATE379990T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computed tomography [CT]
    • A61B6/037—Emission tomography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/40—Arrangements for generating radiation specially adapted for radiation diagnosis
    • A61B6/4057—Arrangements for generating radiation specially adapted for radiation diagnosis by using radiation sources located in the interior of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/42—Arrangements for detecting radiation specially adapted for radiation diagnosis
    • A61B6/4208—Arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector
    • A61B6/425—Arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector using detectors specially adapted to be used in the interior of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/42—Arrangements for detecting radiation specially adapted for radiation diagnosis
    • A61B6/4208—Arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector
    • A61B6/4258—Arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector for detecting non x-ray radiation, e.g. gamma radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/087—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being an annexin, e.g. annexin V

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Radiology & Medical Imaging (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Hydroponics (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
AT98920065T 1997-04-30 1998-04-28 Verfahren zur darstellung von abgestorbenen zellen in-vivo ATE379990T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4539997P 1997-04-30 1997-04-30

Publications (1)

Publication Number Publication Date
ATE379990T1 true ATE379990T1 (de) 2007-12-15

Family

ID=21937648

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98920065T ATE379990T1 (de) 1997-04-30 1998-04-28 Verfahren zur darstellung von abgestorbenen zellen in-vivo

Country Status (16)

Country Link
US (3) US6197278B1 (de)
EP (1) EP1017318B1 (de)
JP (1) JP4963748B2 (de)
KR (1) KR20010020443A (de)
CN (1) CN1265572A (de)
AT (1) ATE379990T1 (de)
AU (1) AU754577B2 (de)
CA (1) CA2288131A1 (de)
DE (1) DE69838811T2 (de)
ES (1) ES2398118T3 (de)
HU (1) HUP0001261A3 (de)
NZ (1) NZ500598A (de)
PL (1) PL336571A1 (de)
RU (1) RU2228765C2 (de)
TW (1) TW541184B (de)
WO (1) WO1998048699A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2398118T3 (es) * 1997-04-30 2013-03-13 The Board Of Trustees Of The Leland Stanford Junior University Procedimiento de formación de imágenes de muerte celular in vivo
US7736651B1 (en) * 2000-11-24 2010-06-15 Sloan-Kettering Institute For Cancer Research Alpha emitting constructs and uses thereof
IL140701A0 (en) * 1998-07-13 2002-02-10 Univ Texas Cancer treatment methods using antibodies to aminophospholipids
US6818213B1 (en) 1998-07-13 2004-11-16 Board Of Regents, The University Of Texas System Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
US6406693B1 (en) 1998-07-13 2002-06-18 Board Of Regents, The University Of Texas System Cancer treatment methods using antibodies to aminophospholipids
EP1098665B9 (de) 1998-07-13 2003-08-13 The Board Of Regents, The University Of Texas System Krebsbehandlung mit aminophospholipide bindenden, therapeutischen konjugaten
US7067111B1 (en) * 1999-10-25 2006-06-27 Board Of Regents, University Of Texas System Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
US6692724B1 (en) 1999-10-25 2004-02-17 Board Of Regents, The University Of Texas System Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
JP5448284B2 (ja) 2000-06-02 2014-03-19 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム エチレンジシステイン（ｅｃ）−薬物結合体
WO2001097678A2 (en) * 2000-06-22 2001-12-27 Henry Ford Health System Imaging and targeting tumors using sickle cells
US20050013778A1 (en) * 2001-04-03 2005-01-20 Theseus Imaging Corporation Methods and compositions for predicting the response to a therapeutic regimen in a subject having a disease associated with cell death
EP1381839A4 (de) * 2001-04-03 2005-10-12 Univ Leland Stanford Junior Verfahren zur bildlichen darstellung von zelltod in vivo
JP2004535375A (ja) * 2001-04-03 2004-11-25 テセウス イメージング コーポレーション 生体内における細胞死の検出および随伴する症状の治療のためのアネキシンの使用方法
EP1389090A2 (de) * 2001-04-26 2004-02-18 Board of Regents, The University of Texas System Diagnostische bildgebende zusammensetzungen, ihre syntheseverfahren und ihre verwendung
US20030202937A1 (en) * 2001-06-05 2003-10-30 Sabbadini Roger A. Minicell-based diagnostics
US20030152513A1 (en) * 2001-09-06 2003-08-14 Imetrix, Inc. Intravascular delivery of therapeutic and imaging agents to stressed and apoptotic cells using annexin V as a targeting vector
US7261875B2 (en) 2001-12-21 2007-08-28 Board Of Regents, The University Of Texas System Dendritic poly (amino acid) carriers and methods of use
US20040042959A1 (en) * 2002-08-28 2004-03-04 Michael Montalto Imaging cell death in vivo using non-radionuclide contrast agents
WO2004044227A2 (en) * 2002-11-07 2004-05-27 Board Of Regents, The University Of Texas System Ethylenedicysteine (ec)-drug conjugates, compositions and methods for tissue specific disease imaging
US20070031333A1 (en) * 2003-01-02 2007-02-08 Mease Ronnie C Novel F-18 labeled annexin V, synthesis thereof, and use thereof
US9050378B2 (en) * 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
RU2386449C2 (ru) * 2004-01-15 2010-04-20 Эйпосенс Лтд. Соединения, связывающиеся с нарушенной мембраной, и их применение
US7511016B2 (en) * 2004-07-07 2009-03-31 Mosamedix B.V. Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof
JP5345383B2 (ja) * 2005-04-22 2013-11-20 コーニンクレッカ フィリップス エヌ ヴェ 検出器画素、放射線検出器および方法、陽電子放出断層撮影システム、撮像検出器およびその較正方法、検出器セルの無効化方法
US7874975B2 (en) * 2005-07-20 2011-01-25 Clear Vascular, Inc. Methods and compositions for treating luminal inflammatory disease
US9623129B2 (en) * 2005-09-26 2017-04-18 Snip Holdings, Inc. Methods and therapies for treating inflammatory conditions with exposed collagen
CA2626392A1 (en) * 2005-10-21 2007-05-03 Immunochemistry Technologies, Llc In vivo detection of apoptosis
US7871623B2 (en) * 2005-12-21 2011-01-18 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for imaging pain and stress in vivo
US8758723B2 (en) 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
CN101490581A (zh) * 2006-07-21 2009-07-22 皇家飞利浦电子股份有限公司 用于改进的tof pet重建的方法和系统
US10925977B2 (en) * 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
JP5468905B2 (ja) * 2007-01-30 2014-04-09 ジーイー・ヘルスケア・リミテッド 神経変性疾患の診断を支援するためのツール
EP2162762B1 (de) * 2007-05-16 2016-06-08 Koninklijke Philips N.V. Virtueller pet-detektor und quasi-gepixeltes ableseschema für pet
US8055039B2 (en) * 2008-02-21 2011-11-08 General Electric Company System and method to obtain noise mitigated monochromatic representation for varying energy level
US8916570B2 (en) 2008-03-31 2014-12-23 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services A3 adenosine receptor agonists and antagonists
ES2531828T3 (es) * 2008-03-31 2015-03-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Derivados de purina como agonistas selectivos de los receptores A3 de adenosina
CA2732320C (en) * 2008-08-01 2017-08-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services A3 adenosine receptor antagonists and partial agonists
US9181253B2 (en) 2008-08-01 2015-11-10 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Adenosine receptor agonists, partial agonists, and antagonists
JP5801196B2 (ja) 2008-08-26 2015-10-28 モサメディックス・ビー．ブイ．ＭｏｓａＭｅｄｉｘ Ｂ．Ｖ． 放射標識アネキシン
US8283167B2 (en) * 2009-02-11 2012-10-09 Clear Vascular Inc. Preparation of annexin derivatives
JP6138759B2 (ja) 2011-04-04 2017-05-31 イデー インターナショナル アールアンドディー インコーポレイテッドＩｄｅｅ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｒ＆Ｄ Ｉｎｃ． 使い捨てシリンジ
US10286093B2 (en) * 2013-05-23 2019-05-14 Neurosn, Inc. Method of diagnosing and treating Alzheimer's disease
CN105669855B (zh) * 2016-02-04 2020-02-11 江苏省原子医学研究所 一种18F快速标记Cys-Annexin V的方法及其应用
RU2622983C1 (ru) * 2016-07-25 2017-06-21 федеральное государственное бюджетное образовательное учреждение высшего образования "Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ интраоперационной визуализации ишемически-реперфузионного повреждения миокарда
WO2019169241A1 (en) * 2018-03-02 2019-09-06 Serene, Llc Methods of treating and imaging ungulate laminitis
JP2024022034A (ja) * 2022-08-05 2024-02-16 浜松ホトニクス株式会社 プログラムされた細胞死を起こした細胞の領域を決定する方法、決定部を備える装置及び決定ステップを含む情報処理プログラム

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665897A (en) * 1984-05-25 1987-05-19 Lemelson Jerome H Composition and method for detecting and treating cancer
US5627036A (en) 1989-12-27 1997-05-06 Boehringer Ingelheim International Gmbh Use of an anticoagulant as a diagnostic agent
US5552525A (en) 1991-02-08 1996-09-03 Diatech Inc. Technetium-99m labeled peptides for imaging inflammation
US5632986A (en) * 1991-05-09 1997-05-27 The University Of Washington Phospholipid-targeted thrombolytic agents
JPH05508664A (ja) 1991-05-09 1993-12-02 ボード・オブ・リージェンツ・オブ・ザ・ユニヴァーシティ・オブ・ワシントン リン脂質標的血栓溶解剤
US5519221A (en) 1992-01-22 1996-05-21 Ansel M. Schwartz Dedicated apparatus and method for emission mammography
EP0627940B1 (de) * 1992-03-05 2003-05-07 Board of Regents, The University of Texas System Verwendung von Immunokonjugate zur Diagnose und/oder Therapie der vaskularisierten Tumoren
US5965132A (en) * 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US5660827A (en) * 1992-03-05 1997-08-26 Board Of Regents, The University Of Texas System Antibodies that bind to endoglin
GB9223168D0 (en) 1992-11-05 1992-12-16 Johnson Matthey Plc Improvements in molecule labelling
US5968477A (en) 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
CA2185535C (en) 1994-04-11 2000-10-24 Christiaan Peter Maria Reutelingsperger A method for detecting and/or optionally quantifying and/or separating apoptotic cells in or from a sample
JPH10504534A (ja) 1994-06-16 1998-05-06 ネオルクス コーポレイション 放射性標識アネキシン−ガラクトース結合体
EP0799050B1 (de) 1994-12-07 2004-08-11 Neorx Corporation Radioaktivmarkierte annexin-galaktose-cluster konjugate
ES2398118T3 (es) * 1997-04-30 2013-03-13 The Board Of Trustees Of The Leland Stanford Junior University Procedimiento de formación de imágenes de muerte celular in vivo
IL140701A0 (en) 1998-07-13 2002-02-10 Univ Texas Cancer treatment methods using antibodies to aminophospholipids
EP1098665B9 (de) 1998-07-13 2003-08-13 The Board Of Regents, The University Of Texas System Krebsbehandlung mit aminophospholipide bindenden, therapeutischen konjugaten
US6406693B1 (en) * 1998-07-13 2002-06-18 Board Of Regents, The University Of Texas System Cancer treatment methods using antibodies to aminophospholipids

Also Published As

Publication number Publication date
EP1017318A1 (de) 2000-07-12
CA2288131A1 (en) 1998-11-05
RU2228765C2 (ru) 2004-05-20
DE69838811T2 (de) 2008-10-30
US7666389B2 (en) 2010-02-23
TW541184B (en) 2003-07-11
ES2398118T3 (es) 2013-03-13
EP1017318A4 (de) 2003-04-23
JP2002500757A (ja) 2002-01-08
US20070243133A1 (en) 2007-10-18
JP4963748B2 (ja) 2012-06-27
PL336571A1 (en) 2000-07-03
AU7271498A (en) 1998-11-24
US6197278B1 (en) 2001-03-06
NZ500598A (en) 2001-09-28
HUP0001261A2 (hu) 2000-08-28
US7357915B2 (en) 2008-04-15
KR20010020443A (ko) 2001-03-15
CN1265572A (zh) 2000-09-06
US20080138279A1 (en) 2008-06-12
DE69838811D1 (de) 2008-01-17
HUP0001261A3 (en) 2001-11-28
AU754577B2 (en) 2002-11-21
WO1998048699A1 (en) 1998-11-05
EP1017318B1 (de) 2007-12-05

Similar Documents

Publication Publication Date Title
ATE379990T1 (de) Verfahren zur darstellung von abgestorbenen zellen in-vivo
EP1124598A4 (de) System zur diagnose von harninkontinenz
ATE400219T1 (de) Verfahren zur quantifizierung von menschlicher wachsamkeit
DE60001564D1 (de) Bicyclische polyamiosaure metallkomplexe, verfahren zu ihrer herstellung und ihre verwendung für medizinische bilderzeugung
DE69921234D1 (de) Dreidimensionales Bildrekonstruktionsverfahren
DE69826207D1 (de) Knochentransplantatverdichter mit horizontalen Stufen für Hüftüberprüfung
DE59804782D1 (de) Gitter für die Fixierung von Knochenteilen oder für die Überbrückung von Knochenfehlstellen
DE69903898D1 (de) Teststreifen zur visuellen Ermittlung der Blutglukose-Konzentration
DE69941563D1 (de) Elektrochemisches System zur Bestimmung der Blutgerinnungszeit
ID21140A (id) Metode produksi asam akrilat
ID27390A (id) Pembuatan asam akrilat
DE69731276D1 (de) Verfahren zur angabe der grösse von minizellen
DE69924968D1 (de) Verfahren zur differenzierung roter nukleierter blutzellen
DE69721021D1 (de) Blasenmukosa mit zellen für die rekonstruktion von geweben
ATE255632T1 (de) Immortalisierung bzw. desimmortalisierung von zellen
DE69940256D1 (de) Zusammensetzung zur hautbleichung
DE59911626D1 (de) Verfahren zur zweidimensionalen Abbildung von Strukturen für die medizinische Diagnostik
DE69826951D1 (de) Verfahren zur Gewebepflege
ATE390939T1 (de) In-vivo verfahren zur messung von auf der haut oder dessen komponenten bindenden aktiven chemischen substanzen
DE69800720D1 (de) Reagenz zur Färbung von Blutzellen
ID23892A (id) Metode pembuatan asam l-glutamat melalui fermentasi
ID17416A (id) Pembuatan asam akrilat
ATE222122T1 (de) Verfahren zur tötung von zielzellen in geernteten zellpopulationen mit hilfe von zwei immunotoxinen
ID19974A (id) Metode untuk mendapatkan kembali asam akrilat
DE69926449D1 (de) Verfahren zur herstellung von pulvrigem nickel

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties